awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26830878-82DAD481-2FE2-496B-A3C6-E7A14FF8DFB6
Q26830878-82DAD481-2FE2-496B-A3C6-E7A14FF8DFB6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26830878-82DAD481-2FE2-496B-A3C6-E7A14FF8DFB6
Current and emerging treatment options for patients with relapsed myeloma
P2860
Q26830878-82DAD481-2FE2-496B-A3C6-E7A14FF8DFB6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26830878-82DAD481-2FE2-496B-A3C6-E7A14FF8DFB6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d83158ab3eaa6a5422693ed706bd07e4f5e41fe9
P2860
An open-label single-arm pilot phase II study (PX-171-003-A0) of low-dose, single-agent carfilzomib in patients with relapsed and refractory multiple myeloma.